Henrik Gréen Selected Research

Henrik Gréen Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 12/2003
9	Ovarian Neoplasms (Ovarian Cancer) 09/2018 - 02/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2014
6	Drug-Related Side Effects and Adverse Reactions 04/2022 - 10/2011
6	Neutropenia 04/2022 - 07/2011
5	Peripheral Nervous System Diseases (PNS Diseases) 05/2024 - 08/2012
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 04/2010
4	Breast Neoplasms (Breast Cancer) 05/2024 - 12/2010
4	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2016
3	Leukopenia 04/2022 - 01/2020
3	Melanoma (Melanoma, Malignant) 06/2017 - 10/2011
2	Lung Neoplasms (Lung Cancer) 01/2016 - 07/2011
1	Hypesthesia (Numbness) 05/2024
1	Substance-Related Disorders (Drug Abuse) 07/2023
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Long QT Syndrome 01/2023
1	Carcinogenesis 11/2022
1	Chronic Pain 02/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Overweight 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Poisoning 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021
1	Diabetes Mellitus 01/2021
1	Delirium 01/2018
1	Multiple Myeloma 01/2018
1	Serotonin Syndrome (Syndrome, Serotonin) 01/2018
1	Seizures (Absence Seizure) 09/2016
1	Unconsciousness (Loss of Consciousness) 12/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	T-Cell Leukemia (Leukemia, T Cell) 07/2011
1	Myeloid Leukemia (Leukemia, Myelocytic) 07/2011
1	Prostatic Neoplasms (Prostate Cancer) 12/2010

Drug/Important Bio-Agent (IBA)

13	Carboplatin (JM8)FDA LinkGeneric 04/2022 - 02/2006
13	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2006
7	Gemcitabine FDA Link 04/2022 - 01/2016
6	Tyrosine Kinase InhibitorsIBA 01/2019 - 07/2011
5	Cytochrome P-450 CYP3AIBA 01/2019 - 02/2009
4	taxaneIBA 05/2024 - 02/2012
3	Imatinib Mesylate (Gleevec)FDA Link 04/2016 - 04/2010
3	Cytochrome P-450 CYP2C8IBA 02/2012 - 02/2009
2	Fentanyl (Sublimaze)FDA LinkGeneric 07/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2020
2	ParaffinIBA 01/2021 - 05/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2014
2	Genetic Markers (Genetic Marker)IBA 01/2020 - 01/2020
2	EnzymesIBA 01/2014 - 12/2010
2	TubulinIBA 08/2012 - 05/2006
2	Canertinib (CI 1033)IBA 10/2011 - 07/2011
2	ErbB Receptors (EGF Receptor)IBA 10/2011 - 07/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2006 - 12/2003
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2023
1	pyrimidineIBA 11/2022
1	RibonucleotidesIBA 11/2022
1	Opioid Analgesics (Opioids)IBA 02/2021
1	Oxycodone (Oxycontin)FDA LinkGeneric 02/2021
1	Analgesics (Analgesic Drugs)IBA 02/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	NucleotidesIBA 01/2020
1	P-2 (P 2)IBA 01/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	PhenethylaminesIBA 01/2018
1	Sympathomimetics (Sympathomimetic Amines)IBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	dabrafenibIBA 06/2017
1	AB-FUBINACAIBA 09/2016
1	CannabinoidsIBA 09/2016
1	VemurafenibIBA 08/2016
1	IsoenzymesIBA 04/2016
1	Therapeutic UsesIBA 01/2016
1	Propofol (Diprivan)FDA LinkGeneric 12/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2014
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 07/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	CaspasesIBA 07/2011
1	Oxidoreductases (Dehydrogenase)IBA 12/2010
1	SteroidsIBA 12/2010

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2024 - 02/2006
2	Therapeutics 06/2008 - 02/2006
1	Precision Medicine 01/2020